戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 cedural myocardial infarction and 1 emergent coronary bypass.
2                        The risk of emergency coronary bypass also was reduced by stenting (0.3% vs. 0
3  manifesting a steeper rise after age 75 for coronary bypass and approaching octogenarian age for iso
4 do AVR, the rest were combination surgeries (coronary bypass and/or aortic surgeries).
5 ry (36% isolated AV surgery, 16% concomitant coronary bypass, and 58% aortic replacement), and 262 pa
6 ocardial infarction, stable/unstable angina, coronary bypass, and coronary angiography), ischemic str
7 on, percutaneous coronary intervention, redo coronary bypass, and the composite of all events identif
8 gery, 88.3%; aortic valve replacement, 4.5%; coronary bypass + aortic valve replacement, 7.1%) had ri
9 utcome assessment, and also the dominance of coronary bypass being threatened by the success of inter
10                                     Combined coronary bypass (CABG) and mitral procedures have been a
11  severe left ventricular dysfunction, repeat coronary bypass carries a higher surgical mortality than
12 onsecutive patients who received the RA as a coronary bypass conduit at our institution.
13  The RA is becoming a recognized alternative coronary bypass conduit.
14                 Five years after surgery, RA coronary bypass conduits grafted to a single coronary te
15 t early and late occlusion of saphenous vein coronary bypass conduits.
16 evolution in cardiac surgical techniques for coronary bypass graft (CABG) surgery has occurred.
17 rals on myocardial functional recovery after coronary bypass graft (CABG) surgery in a group of patie
18 orphological alterations of a biorestorative coronary bypass graft in an animal model.
19 previous myocardial infarction (MI) (45.8%), coronary bypass graft surgery (39.2%), chronic renal fai
20 ransluminal coronary angioplasty (PTCA), and coronary bypass graft surgery (CABG).
21 aneous transluminal coronary angioplasty and coronary bypass graft surgery in patients with symptomat
22                   An acute renal event after coronary bypass graft surgery is associated with high mo
23  Trial randomized patients with a history of coronary bypass graft surgery to either an aggressive or
24 nd descriptive study of 4801 patients having coronary bypass graft surgery with cardiopulmonary bypas
25  race, treatment assignment, and years since coronary bypass graft surgery, a CES-D score > or =16 wa
26 efore the AMI, younger age, history of prior coronary bypass graft surgery, and non-white race.
27 ortality and morbidity compared with on-pump coronary bypass graft surgery.
28 ta on the luminal anatomy of a bioresorbable coronary bypass graft with an endoluminal "flap" identif
29 fits of multiarterial versus single-arterial coronary bypass grafting (CABG) are debated.
30 ingle internal thoracic arteries (SITAs) for coronary bypass grafting (CABG) remains to be determined
31 percutaneous coronary intervention (PCI) and coronary bypass grafting (CABG) surgery exist.
32 t who had received blood transfusions during coronary bypass grafting 9 years earlier.
33 , and at 2, 4, 12, and 20 hrs after elective coronary bypass grafting in 31 patients.
34                       Revascularization with coronary bypass grafting or percutaneous coronary interv
35 herapy of atrial fibrillation concomitant to coronary bypass grafting using epicardial Ultrasound tec
36 nts underwent coronary CTA, of whom 113 with coronary bypass grafting were excluded.
37 n (mean LVEF, 24.0%; SD, 8.3%) scheduled for coronary bypass grafting were recruited.
38 ion fraction) and women (age and concomitant coronary bypass grafting).
39 were obtained in 15 male patients undergoing coronary bypass grafting, all with normal left ventricul
40  arterial disease, previous stroke, previous coronary bypass grafting, heart failure, and renal dysfu
41 branches or adjacent arch vessels, and 3 had coronary bypass grafting.
42  a nested case-control substudy of the CAGE (CoronAry bypass grafting: factors related to late events
43 uld suggest more natural ways of engineering coronary bypass grafts and revascularizing the heart.
44 uring stenting of degenerated saphenous vein coronary bypass grafts are reduced, but not eliminated,
45 long-term patency of internal mammary artery coronary bypass grafts compared with venous grafts has b
46               Degeneration of saphenous vein coronary bypass grafts has become a common problem.
47                            Additionally, all coronary bypass grafts were rated as patent or occluded.
48 71%) were undergoing reoperation with patent coronary bypass grafts, and 5 (16%) had a porcelain asce
49  peripheral arterial disease, saphenous vein coronary bypass grafts, and diabetic retinopathy.
50  cardiac lesions, prosthetic valves, stents, coronary bypass grafts, and implanted devices are at gre
51 reatment for stenotic saphenous venous aorto-coronary bypass grafts, but their placement carries a 20
52                                Patients with coronary bypass grafts, chronic total occlusions, and th
53 omyopathy, angina, heart transplantation and coronary bypass grafts, coronary artery disease, diabeti
54              As compared with saphenous-vein coronary bypass grafts, internal-thoracic-artery grafts
55 eater than 74, 78, and 75 years for isolated coronary bypass, isolated valve surgery, and coronary by
56 d perfusion during minimally invasive direct coronary bypass (MIDCAB).
57 natherosclerotic repair arteries gathered at coronary bypass operations from 30 patients with type 2
58                    We reviewed 9442 isolated coronary bypass operations performed from 1989 through 1
59 on (MI); angina pectoris; and performance of coronary bypass or angioplasty.
60 early morbidity and mortality in reoperative coronary bypass patients with a reduced EF (<36%).
61 coronary bypass, isolated valve surgery, and coronary bypass plus valve surgery, respectively.
62                                Multiarterial coronary bypass procedures offer improved clinical outco
63 22 patients with severe saphenous vein aorto-coronary bypass stenoses.
64 ngioplasty (32.5% versus 13.2%, P<.0001), or coronary bypass surgery (12.5% versus 9.5%, P<.0001).
65 e were obtained from 386 patients undergoing coronary bypass surgery (127 with type 2 diabetes).
66 ervention (32.1% versus 23.8%; P<0.001), and coronary bypass surgery (9.2% versus 5.7%; P<0.001).
67 al artery in 53 patients who were undergoing coronary bypass surgery (age 60+/-11 years; 13% female).
68                                              Coronary bypass surgery (CABG) and angioplasty (PTCA) ha
69 based secondary preventive medications after coronary bypass surgery (CABG) and percutaneous coronary
70 se saphenous vein grafts to the aorta during coronary bypass surgery (CABG) without cross-clamping.
71 grafting (re-CABG) in patients with previous coronary bypass surgery (CABG).
72 of initial coronary angioplasty (n = 198) or coronary bypass surgery (n = 194) for patients with mult
73 k 6 weeks sooner than patients who underwent coronary bypass surgery (P < 0.001), but long-term emplo
74 ce interval, 0.56 to 0.81], respectively) or coronary bypass surgery (relative risk, 0.72 [95 percent
75 nsmural endomyocardial biopsy at the time of coronary bypass surgery (two biopsies per patient for a
76 ong-term cognitive function is similar after coronary bypass surgery and coronary angioplasty in the
77 ss repeat interventions, in particular, less coronary bypass surgery and have similar long-term survi
78 e neointima formation in vein grafts used in coronary bypass surgery and in improving methods of myoc
79 en aspirin usage within the 5 days preceding coronary bypass surgery and risk of adverse in-hospital
80                                     Off-pump coronary bypass surgery and the newest generation of dru
81         Two other deaths occurred, one after coronary bypass surgery and the other from hepatic failu
82 larization via percutaneous interventions or coronary bypass surgery are appropriate in specific case
83 ute changes in renal function after elective coronary bypass surgery are incompletely characterized a
84              Adverse cerebral outcomes after coronary bypass surgery are relatively common and seriou
85 tients, patients are referred frequently for coronary bypass surgery because of residual thrombus and
86 e individuals who underwent primary isolated coronary bypass surgery between June 1, 2001, and Januar
87  death, myocardial infarction, and emergency coronary bypass surgery combined was lower (4.9% versus
88 emilofiban there was 1 death after emergency coronary bypass surgery complicated by severe bleeding d
89 pare percutaneous coronary intervention with coronary bypass surgery for multivessel coronary disease
90   The risk of atrial fibrillation (AF) after coronary bypass surgery has been related to redox state,
91 r viability preoperatively who still undergo coronary bypass surgery have a high rate of early and la
92 gher operative and long-term mortality after coronary bypass surgery have been reported in women comp
93 on by percutaneous coronary interventions or coronary bypass surgery have been shown to improve outco
94 ates that direct cardiac SWT, in addition to coronary bypass surgery improves LVEF and physical capac
95  repeat angioplasty in 28 patients (28%) and coronary bypass surgery in 2 patients (2%); the overall
96 cal trial of robotically assisted endoscopic coronary bypass surgery in the United States showed favo
97  changes in cerebral function after elective coronary bypass surgery is a difficult clinical problem.
98                              Whether PTCA or coronary bypass surgery is more suitable for these patie
99                   Early use of aspirin after coronary bypass surgery is safe and is associated with a
100                                              Coronary bypass surgery often leads to short-term cognit
101 re, 75 (61.5%) had PTCA only, 30 (24.6%) had coronary bypass surgery only, and 17 (13.9%) had both pr
102 sease in patients who are not candidates for coronary bypass surgery or angioplasty.
103                                              Coronary bypass surgery or balloon angioplasty.
104 e and a potential viable alternative to open coronary bypass surgery or multivessel stenting.
105 plantation with no antiarrhythmic therapy in coronary bypass surgery patients who had a left ventricu
106  mortality and postoperative morbidity after coronary bypass surgery persist with Black patients and
107 ects with DPT had a more frequent history of coronary bypass surgery than referents (19% versus 2%; p
108 -old man developed acute renal failure after coronary bypass surgery that had been complicated by ste
109 lity failed to deliver effective guidance of coronary bypass surgery to a reduction of adverse cardia
110 ts, myocardial biopsies were obtained during coronary bypass surgery to assess glucose transporter (G
111 nated comparative information on outcomes of coronary bypass surgery to the public.
112 of this study was to evaluate outcomes after coronary bypass surgery versus coronary angioplasty in 5
113 farction, repeated coronary angioplasty, and coronary bypass surgery was determined for 479 patients
114                                              Coronary bypass surgery was needed in 7.5 percent of the
115 ative quantitative 201Tl scintigraphy before coronary bypass surgery were analyzed retrospectively.
116 biopsy specimens from 37 patients undergoing coronary bypass surgery were collected.
117 ng concomitant cardiac operations except for coronary bypass surgery were excluded.
118  vessel segments from 19 patients undergoing coronary bypass surgery were incubated with or without c
119 ive heart failure, myocardial infarction, or coronary bypass surgery were less likely to receive repe
120 articular the internal mammary arteries, for coronary bypass surgery whenever possible.
121 patients of any age undergoing contemporary, coronary bypass surgery will receive at least 1 saphenou
122 ocedures (coronary angioplasty, stenting, or coronary bypass surgery) performed by individual practit
123 mbosis; saphenous vein graft occlusion after coronary bypass surgery), and particularly those with di
124 of myocardial infarction was 2.7%; emergency coronary bypass surgery, 1.4%; and death, 0.5%.
125       Among patients with diabetes, previous coronary bypass surgery, as compared with coronary angio
126 ft anterior descending artery is standard in coronary bypass surgery, but controversy exists on the b
127  hibernation and may still be candidates for coronary bypass surgery, even in the absence of angina.
128 with inducible ischemia were revascularized (coronary bypass surgery, n = 67 or angioplasty, n = 11).
129 ospectively studied 5065 patients undergoing coronary bypass surgery, of whom 5022 survived the first
130 patients were free of myocardial infarction, coronary bypass surgery, or additional percutaneous inte
131 e death, all myocardial infarction, emergent coronary bypass surgery, or clinically indicated target
132 ted with improved ventricular function after coronary bypass surgery, the relationship between viabil
133 eath (0.5%), and 2 patients (0.9%) underwent coronary bypass surgery.
134 8 +/- 5 weeks after myocardial infarction or coronary bypass surgery.
135 r redox signaling in 633 patients undergoing coronary bypass surgery.
136 zed imaging protocol for patients undergoing coronary bypass surgery.
137 cardiac SWT or sham treatment in addition to coronary bypass surgery.
138 urvival benefit of BIMA up to 10 years after coronary bypass surgery.
139 rsus closed tunnel endoscopic harvesting for coronary bypass surgery.
140       LV biopsy samples were obtained during coronary bypass surgery.
141 ubjected to cardiac ischemia, such as during coronary bypass surgery.
142 uce the risk of complications or death after coronary bypass surgery.
143 and thallium-201 ((201)Tl) tomography before coronary bypass surgery.
144 on (MI), 32% had prior PCI and 19% had prior coronary bypass surgery.
145 nt with aspirin could improve survival after coronary bypass surgery.
146 e diabetes mellitus, hypertension, and prior coronary bypass surgery.
147 cost are less than for conventional repeated coronary bypass surgery.
148 causing suboptimal myocardial function after coronary bypass surgery.
149 shorter convalescence than those who undergo coronary bypass surgery.
150 y angioplasty: OR 0.60, 95% CI 0.25 to 1.49; coronary bypass surgery: OR 0.22, 95% CI 0.08 to 0.63; a
151 ts, five were treated medically and one with coronary bypass surgery; three died.
152 ry of coronary-artery disease, hypertension, coronary-bypass surgery and cerebral ischaemia, smoking
153 ) remnants obtained from patients undergoing coronary bypass surgical procedures have impaired endoth
154 immediate Palmaz-Schatz coronary stenting of coronary bypass vein grafts.
155 ion by percutaneous coronary intervention or coronary bypass was lower in DES patients (adjusted HR 0

 
Page Top